Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Array BioPharma Inc. - Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2009
FibroGen, Inc. - FibroGen Announces New Research at Stanford University School of Medicine Indicates That Inhibiting CTGF Could Have Therapeutic Benefits in Treating Pancreatic Cancer
InnovationsKapital - InnovationsKapital: Hope for Sufferers of Post-Amputation Pain
Non-Small Cell Lung Cancer - OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer
Pediatrics - New Retin-A Micro® Pump Study Shows High Rates of Compliance and Efficacy for Patients Suffering from Acne
Breast Cancer - Reports from Mayo Clinic add new data to research in breast cancer
Cancer Vaccines - Reports from University of Birmingham advance knowledge in cancer vaccines
Life Sciences - Scientists at Virginia Commonwealth University detail research in life sciences
Mesothelioma - Findings from Emory University in mesothelioma reported
Multiple Sclerosis - Findings from St. Michael's Hospital in multiple sclerosis reported
Non-Small Cell Lung Cancer - Findings from University of North Carolina provide new insights into non-small cell lung cancer
Non-Small Cell Lung Cancer - Report summarizes non-small cell lung cancer study findings from University of Wisconsin
Oncology - Study results from A.M. Davies and colleagues update understanding of oncology
Pancreatic Cancer - Findings from University of Zurich advance knowledge in pancreatic cancer
Pharmacodynamics - Research from J.M. Hamilton and co-researchers in the area of pharmacodynamics described
Phototherapy - Research from Cleveland Clinic in the area of phototherapy published
Sepsis - Reports outline sepsis study results from Pfizer Inc.
Small Cell Lung Cancer - Research from S. Jalal and co-researchers in the area of small cell lung cancer described
Colon Cancer Therapy - New data from University of Pittsburgh, Department of Surgery illuminate research in colon cancer therapy
Lymphoma Therapy - Research from M.B. van 't Veer et al broadens understanding of lymphoma therapy
Paresis - Research from Oregon Health & Science University, Neurological Sciences Institute broadens understanding of paresis
Solid Cancer - Reports summarize solid cancer research from Kinki University
Acid Reflux Disease - FDA Approves KAPIDEX (dexlansoprazole) delayed release capsules for the Treatment of GERD
Alcoholism - Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
Alzheimer Disease - Anavex scales up synthesis of ANAVEX 2-73 for Phase 1 Alzheimer's disease study
Biotechnology Business - Cephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
Breast Cancer - Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients
Bronchitis - BioMarck Pharmaceuticals Awarded $990,000 Grant by National Institutes of Health
Cancer - Cancer Therapy & Research Center at the University of Texas Health Science Center and Oncolytics Biotech® Inc. Announce Multi-Trial Clinical Research Collaboration
Clinical Trial Research - Results From Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease Not Statistically Significant
Clinical Trial Research - Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
CyDex Pharmaceuticals - CyDex Pharmaceuticals Announces Successful Completion of Phase II Clinical Trial for Budesonide/Azelastine Combination Solution Nasal Spray
Diabetes - Isis Initiates Phase 1 Clinical Trial of SGLT2 Antisense Drug
Drug Development - Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist
FibroGen, Inc. - Patient Recruitment Resumes in FibroGen Phase 2 Study of Investigational Oral HIF-PH Inhibitor, FG-4592/ASP1517, for the Treatment of Anemia Associated with Chronic Kidney Disease
HIV/AIDS - Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
Idenix Pharmaceuticals, Inc. - Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV
iTherX Pharmaceuticals Inc. - iTherX Pharmaceuticals to Initiate Proof of Concept Clinical Study for First-in-Class Treatment for Hepatitis C
Mayo Clinic - Mayo Clinic researchers find experimental therapy turns on tumor suppressor gene in cancer cells
Multiple Sclerosis - Acorda Therapeutics Submits New Drug Application for Fampridine-SR for Improvement of Walking Ability in People with Multiple Sclerosis
NovaBay Pharmaceuticals, Inc. - NovaBay Pharmaceuticals NBY CEO Dr. Ron Najafi To Present at the 11th Annual BIO CEO & Investor Conference
Omnia Biologics, Inc. - Omnia Biologics and Sumagen Announce Successful Manufacture of HIV/AIDS Vaccine Phase I Material
Pfizer Inc - Pfizer Discontinues Global Phase III Trial of Axitinib for Futility in Advanced Pancreatic Cancer
Rexahn Pharmaceuticals, Inc. - Rexahn Pharmaceuticals, Inc. Initiates Clinical Trial of SerdaxinTM to Treat Depression
Seattle Genetics, Inc. - Seattle Genetics Reports Fourth Quarter and Year 2008 Financial Results and Provides 2009 Financial Outlook
Standard & Poor’s - Standard & Poor's Initiates Factual Stock Report Coverage on GeoVax Labs, Inc.
